Company intelligence / Profile preview

King Pharmaceuticals, Inc.

Bristol, Tennessee, United Statesking-pharma.com ↗

Ownership: Private
Employees: ~3000
Development stage: Commercial

Overview

Prior to its acquisition by Pfizer in early March of 2011, King Pharmaceuticals was a commercial-stage specialty pharmaceutical company with a portfolio focused on pain management, cardiovascular disease, emergency medicine devices such as the EpiPen auto-injector, and animal health. Its key product Altace benefited from strong clinical data showing significant reduction in cardiovascular events. The company also developed new formulations designed to deter opioid misuse and abuse. At the time of acquisition it had several marketed products but limited late-stage R&D activity.

Therapeutic areas: EndocrinologyImmunologyOtherCardiovascularNeurologyWomen's Health
Modalities: small moleculesdrug-device combinations
Industry: Biotech

Drug pipeline

6 assets

ramipril

Commercial

Indications: Hypertension

5 more assets in the full pipeline.

Request access →

Partnerships

U.S. Department of Defense for supply of emergency injectors/EpiPenTecnofarma S.A. for Menest in Latin America

Beyond the preview

Go deeper on King Pharmaceuticals, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on King Pharmaceuticals, Inc..

Explore the full profile